» Articles » PMID: 11913997

The Potential Role of Thrombopoietin in Idiopathic Thrombocytopenic Purpura

Overview
Journal Blood Rev
Publisher Elsevier
Specialty Hematology
Date 2002 Mar 27
PMID 11913997
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Thrombopoietin (TPO) plays a central role in the pathogenesis of idiopathic thrombocytopenic purpura (ITP), as it does in other immune-mediated thrombocytopenias. Because TPO is bound and internalized by platelets, it is destroyed together with platelets at an accelerated rate in the macrophage system. Because the spleen acts as a TPO sink, compensation of the decreased platelet count by an increased production in the bone marrow is insufficient. This aspect of ITP, as well as the use of TPO in the treatment of ITP, will be the focus of this article.

Citing Articles

PrACTiC: A Predictive Algorithm for Chemoradiotherapy-Induced Cytopenia in Glioblastoma Patients.

Amouheidari A, Alirezaei Z, Rauh S, Hassanpour M J Oncol. 2022; 2022:1438190.

PMID: 35111223 PMC: 8803420. DOI: 10.1155/2022/1438190.


From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag.

Gill H, Wong R, Kwong Y Ther Adv Hematol. 2017; 8(5):159-174.

PMID: 28473904 PMC: 5407506. DOI: 10.1177/2040620717693573.


Advances in immunopathogenesis of adult immune thrombocytopenia.

Liu X, Hou Y, Peng J Front Med. 2013; 7(4):418-24.

PMID: 24264165 DOI: 10.1007/s11684-013-0297-8.


A multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopenia.

Wang S, Yang R, Zou P, Hou M, Wu D, Shen Z Int J Hematol. 2012; 96(2):222-8.

PMID: 22753022 DOI: 10.1007/s12185-012-1124-8.